Evaluation for LGE and Cardiac Parameters on Artificial Intelligence in Patients With Cardiomyopathy

Evaluation for Cardiac Parameters on Artificial Intelligence in Patients With Cardiomyopathy

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025488

Enrollment

Unknown

Registered

2019-08-28

Start date

2019-09-01

Completion date

Unknown

Last updated

2019-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiomyopathy

Interventions

Gold Standard:Ultrasound, electrocardiogram and laboratory examination.

Index test:Gadolinium&#32

enhancement

&#32

Left-ventricular&#32

parameters&#32

on&#32

Artificial&#32

Intelligence.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with presumptively clinical diagnosis of cardiomyopathy in accordance with a combination of clinical signs and symptoms, including chest pain, exhaustion and palpitations, as well as 24-hour dynamic electrocardiographic abnormities.

Exclusion criteria

Exclusion criteria: 1) Patients with cardiac pacemaker, aneurysm clip, artificial heart valve, etc. 2) metal prostheses, metal joints and ferromagnetic foreign bodies (shrapnel, etc.) in the body; 3) claustrophobic patients; 4) Severe arrhythmias (especially atrial fibrillation, ventricular fibrillation, atrioventricular block, etc.); 5) Severe renal insufficiency; 6) There has been a history of severe allergies to drugs or contrast agents in the past.

Design outcomes

Primary

Measure	Time frame
Gadolinium enhancement;Left-ventricular parameters on Artificial Intelligence;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactWeifeng Yuan

The First Affiliated Hospital of Chengdu Medical College

yuanweifeng3721@hotmail.com+86 18200333803

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026